Matrix metalloproteinase inhibition. From the Jurassic to the third millennium

Ann N Y Acad Sci. 1999 Jun 30:878:388-403. doi: 10.1111/j.1749-6632.1999.tb07697.x.

Abstract

A brief historical introduction to the matrix metalloproteinase (MMP) field, which began in 1962, is followed by an overview of the inhibition of these proteases by natural inhibitors such as alpha 2 macroglobulin and the TIMPs (tissue inhibitors of metalloproteinases) and by synthetic inhibitors, which are largely chelating agents. The latter include thiol, alkylcarbonyl, phosponamidate and hydroxamate compounds, as well as the tetracyclines. A review of the most recent progress concludes with prognostications as to where the field may be going next.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Chelating Agents / pharmacology
  • Humans
  • Metalloendopeptidases / antagonists & inhibitors*
  • Protease Inhibitors / chemical synthesis
  • Protease Inhibitors / pharmacology*
  • Tissue Inhibitor of Metalloproteinases / metabolism*
  • Tissue Inhibitor of Metalloproteinases / pharmacology
  • Tumor Cells, Cultured

Substances

  • Chelating Agents
  • Protease Inhibitors
  • Tissue Inhibitor of Metalloproteinases
  • Metalloendopeptidases